{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:14:55Z","timestamp":1759637695553,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12031-019-01443-4","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T18:02:43Z","timestamp":1576692163000},"page":"504-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment"],"prefix":"10.1007","volume":"70","author":[{"given":"Hedyeh Fazel","family":"Tolami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Sharafshah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laleh Fazel","family":"Tolami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1093-6051","authenticated-orcid":false,"given":"Parvaneh","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"issue":"4","key":"1443_CR1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12031-018-1123-1","volume":"65","author":"M Ahmed","year":"2018","unstructured":"Ahmed M, Ul Haq I, Faisal M, Waseem D, Taqi MM (2018) Implication of OPRM1 A118G polymorphism in opioids addicts in Pakistan: in vitro and in silico analysis. J Mol Neurosci 65(4):472\u2013479","journal-title":"J Mol Neurosci"},{"issue":"4","key":"1443_CR2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10550887.2017.1361724","volume":"36","author":"A Albonaim","year":"2017","unstructured":"Albonaim A, Fazel H, Sharafshah A, Omarmeli V, Rezaei S, Ajamian F, Fazel H, Sharafshah A, Omarmeli V, Rezaei S, Ajamian F, Keshavarz P (2017) Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population. J Addict Dis 36(4):227\u2013235","journal-title":"J Addict Dis"},{"key":"1443_CR3","doi-asserted-by":"publisher","unstructured":"Amato L, Davoli M, Ferri MM, Ali R (2003) Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev (2):CD003409. https:\/\/doi.org\/10.1002\/14651858.CD003409","DOI":"10.1002\/14651858.CD003409"},{"issue":"3","key":"1443_CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pain.2005.11.005","volume":"120","author":"P Athanasos","year":"2006","unstructured":"Athanasos P, Smith CS, White JM, Somogyi AA, Bochner F, Ling WJP (2006) Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations. Pain 120(3):267\u2013275","journal-title":"Pain"},{"issue":"2","key":"1443_CR5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300598","volume":"30","author":"G Bart","year":"2005","unstructured":"Bart G, Kreek MJ, Ott J, LaForge KS, Proudnikov D, Pollak L, Heilig MJN (2005) Increased attributable risk related to a functional \u03bc-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 30(2):417","journal-title":"Neuropsychopharmacology"},{"issue":"16","key":"1443_CR6","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","volume":"95","author":"C Bond","year":"1998","unstructured":"Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L et al (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters \u03b2-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 95(16):9608\u20139613","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1443_CR7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/clpt.2010.127","volume":"88","author":"H Bunten","year":"2010","unstructured":"Bunten H, Liang W, Pounder D, Seneviratne C, Osselton DJCP, Therapeutics (2010) OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths. Clin Pharmacol Ther 88(3):383\u2013389","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1443_CR8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1369-1600.2010.00274.x","volume":"16","author":"H Bunten","year":"2011","unstructured":"Bunten H, Liang WJ, Pounder D, Seneviratne C, Osselton MD (2011) CYP2B6 and OPRM1 gene variations predict methadone-related deaths. Addict Biol 16(1):142\u2013144","journal-title":"Addict Biol"},{"issue":"1","key":"1443_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"Vincent B. Chen","year":"2009","unstructured":"Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ et al (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallographica Section D: Biological Crystallography 66(1):12\u201321","journal-title":"Acta Crystallographica Section D Biological Crystallography"},{"key":"1443_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neulet.2013.02.018","volume":"542","author":"Toni-Kim Clarke","year":"2013","unstructured":"Clarke T-K, Crist RC, Kampman KM, Dackis CA, Pettinati HM, O\u2019Brien CP et al (2013) Low frequency genetic variants in the \u03bc-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. Neuroscience letters 542:71\u201375","journal-title":"Neuroscience Letters"},{"issue":"9","key":"1443_CR11","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein science 2(9):1511\u20131519","journal-title":"Protein science"},{"issue":"1-2","key":"1443_CR12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2008.02.004","volume":"96","author":"RP Corley","year":"2008","unstructured":"Corley RP, Zeiger JS, Crowley T, Ehringer MA, Hewitt JK, Hopfer CJ et al (2008) Association of candidate genes with antisocial drug dependence in adolescents. Drug Alcohol Depend 96(1-2):90\u201398","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1443_CR13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1471-4159.2009.06472.x","volume":"112","author":"I Deb","year":"2010","unstructured":"Deb I, Chakraborty J, Gangopadhyay PK, Choudhury SR, Das S (2010) Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. J Neurochem 112(2):486\u2013496","journal-title":"J Neurochem"},{"issue":"8","key":"1443_CR14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","volume":"193","author":"VP Dole","year":"1965","unstructured":"Dole VP, Nyswander MJJ (1965) A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. JAMA 193(8):646\u2013650","journal-title":"JAMA"},{"issue":"10","key":"1443_CR15","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1360-0443.2005.01232.x","volume":"100","author":"EC Donny","year":"2005","unstructured":"Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SLJA (2005) Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction 100(10):1496\u20131509","journal-title":"Addiction"},{"issue":"20","key":"1443_CR16","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1073\/pnas.0600871103","volume":"103","author":"K. Drakenberg","year":"2006","unstructured":"Drakenberg K, Nikoshkov A, Horv\u00e1th MC, Fagergren P, Gharibyan A, Saarelainen K et al (2006) \u03bc Opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proceedings of the National Academy of Sciences 103(20):7883\u20137888","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"14","key":"1443_CR17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","volume":"41","author":"CB Eap","year":"2002","unstructured":"Eap CB, Buclin T, Baumann PJC (2002) Interindividual variability of the clinical pharmacokinetics of methadone. Clin Pharmacokinet 41(14):1153\u20131193","journal-title":"Clin Pharmacokinet"},{"key":"1443_CR18","doi-asserted-by":"publisher","unstructured":"Gowing L, Ali R, White J (2009) Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database Syst Rev (4). https:\/\/doi.org\/10.1002\/14651858.CD002021","DOI":"10.1002\/14651858.CD002021"},{"issue":"15","key":"1443_CR19","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","volume":"18","author":"N Guex","year":"1997","unstructured":"Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-Pdb Viewer: an environment for comparative protein modeling. electrophoresis. Electrophoresis 18(15):2714\u20132723","journal-title":"Electrophoresis"},{"issue":"7","key":"1443_CR20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/pgs.13.57","volume":"14","author":"BS Haerian","year":"2013","unstructured":"Haerian BS, Haerian MSJP (2013) OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. Pharmacogenomics 14(7):813\u2013824","journal-title":"Pharmacogenomics"},{"issue":"9","key":"1443_CR21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/FPC.0b013e3283050107","volume":"18","author":"AD Johnson","year":"2008","unstructured":"Johnson AD, Zhang Y, Papp AC, Pinsonneault JK, Lim J-E, Saffen D et al (2008a) Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Pharmacogenet Genomics 18(9):781","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"1443_CR22","doi-asserted-by":"crossref","first-page":"R1599","DOI":"10.1152\/ajpregu.00020.2008","volume":"295","author":"SM Johnson","year":"2008","unstructured":"Johnson SM, Kinney ME, Wiegel LM (2008b) Inhibitory and excitatory effects of \u03bc-, \u03b4-, and \u03ba-opioid receptor activation on breathing in awake turtles Trachemys scripta. Am J Physiol Regul Integr Comp Physiol 295(5):R1599\u2013R1612","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"1443_CR23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","volume":"10","author":"LA Kelley","year":"2015","unstructured":"Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nature protocols 10(6):845\u2013858","journal-title":"Nature protocols"},{"issue":"6","key":"1443_CR24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.1973.03220060039009","volume":"223","author":"M. J. Kreek","year":"1973","unstructured":"Kreek MJJJ (1973) Medical safety and side effects of methadone in tolerant individuals. Jama 223(6):665\u2013668","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"10","key":"1443_CR25","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI60390","volume":"122","author":"MJ Kreek","year":"2012","unstructured":"Kreek MJ, Levran O, Reed B, Schlussman SD, Zhou Y, Butelman ERJT (2012) Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest 122(10):3387\u20133393","journal-title":"J Clin Invest"},{"issue":"7","key":"1443_CR26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1601-183X.2008.00410.x","volume":"7","author":"O. Levran","year":"2008","unstructured":"Levran O, Londono D, O\u2019hara K, Nielsen D, Peles E, Rotrosen J et al (2008) Genetic susceptibility to heroin addiction: a candidate gene association study. Genes, Brain and Behavior 7(7):720\u2013729","journal-title":"Genes, Brain and Behavior"},{"key":"1443_CR27","unstructured":"Lu LJP p (2015) The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. Pain physician 18:131\u2013152"},{"key":"1443_CR28","doi-asserted-by":"publisher","unstructured":"Mattick RP, Breen C, Kimber J, Davoli MJCdosr (2009) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev (3):CD002209. https:\/\/doi.org\/10.1002\/14651858.CD002209","DOI":"10.1002\/14651858.CD002209"},{"key":"1443_CR29","doi-asserted-by":"crossref","first-page":"1744-8069-2-14","DOI":"10.1186\/1744-8069-2-14","volume":"2","author":"Mitchell B Max","year":"2006","unstructured":"Max MB, Wu T, Atlas SJ, Edwards RR, Haythornthwaite JA, Bollettino AF, Hipp HS et al (2006) A clinical genetic method to identify mechanisms by which pain causes depression and anxiety. Molecular Pain 2(1):1744\u20138069","journal-title":"Molecular Pain"},{"issue":"3","key":"1443_CR30","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"S Miller","year":"1988","unstructured":"Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids research 16(3):1215","journal-title":"Nucleic acids research"},{"issue":"16","key":"1443_CR31","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Garrett M. Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791","journal-title":"Journal of Computational Chemistry"},{"key":"1443_CR32","doi-asserted-by":"crossref","unstructured":"Nielsen D, Ji F, Yuferov V, Ho A, Chen A, Levran O et al (2008) Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. Molecular psychiatry 13(4):417","DOI":"10.1038\/sj.mp.4002147"},{"issue":"1","key":"1443_CR33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.drugalcdep.2010.12.026","volume":"117","author":"Momchil A. Nikolov","year":"2011","unstructured":"Nikolov MA, Beltcheva O, Galabova A, Ljubenova A, Jankova E, Gergov G et al (2011) No evidence of association between 118A > G OPRM1 polymorphism and heroin dependence in a large Bulgarian case\u2013control sample. Drug and alcohol dependence 117(1):62\u201365","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"1443_CR34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000093099","volume":"53","author":"Daisuke Nishizawa","year":"2006","unstructured":"Nishizawa D, Han W, Hasegawa J, Ishida T, Numata Y, Sato T et al (2006) Association of \u03bc-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population. Neuropsychobiology 53(3):137\u2013141","journal-title":"Neuropsychobiology"},{"issue":"10","key":"1443_CR35","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1074\/jbc.M807030200","volume":"284","author":"Bruno Georg Oertel","year":"2008","unstructured":"Oertel BG, Kettner M, Scholich K, Renn\u00e9 C, Roskam B, Geisslinger G et al (2009) A common human \u03bc-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. J Biol Chem 284(10):6530\u20136535","journal-title":"Journal of Biological Chemistry"},{"key":"1443_CR36","doi-asserted-by":"crossref","unstructured":"Olesen AE, Sato H, Nielsen LM, Staahl C, Droney J, Gretton S et al (2015) The genetic influences on oxycodone response characteristics in human experimental pain. Fundamental & Clinical Pharmacology 29(4):417\u2013425","DOI":"10.1111\/fcp.12128"},{"issue":"7","key":"1443_CR37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2217\/pgs.09.63","volume":"10","author":"Grace SY Pang","year":"2009","unstructured":"Pang GS, Wang J, Wang Z, Goh C, Lee CGJP (2009) The G allele of SNP E1\/A118G at the \u03bc-opioid receptor gene locus shows genomic evidence of recent positive selection. Pharmacogenomics 10(7):1101\u20131109","journal-title":"Pharmacogenomics"},{"key":"1443_CR38","unstructured":"Rahimi Movaghar A, Mohammad K, Razzaghi EJHRJ (2002) Trend of drug abuse situation in Iran: a three-decade survey. Hakim Res J 5(3):171\u2013181"},{"issue":"3","key":"1443_CR39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-006-0504-2","volume":"188","author":"R. Ray","year":"2006","unstructured":"Ray R, Jepson C, Patterson F, Strasser A, Rukstalis M, Perkins K et al (2006) Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Psychopharmacology 188(3):355\u2013363","journal-title":"Psychopharmacology"},{"key":"1443_CR40","doi-asserted-by":"crossref","unstructured":"Savage SR, Kirsh KL, Passik SDJA s, practice, c (2008) Challenges in using opioids to treat pain in persons with substance use disorders. Addiction science & clinical practice 4(2):4","DOI":"10.1151\/ascp08424"},{"issue":"11","key":"1443_CR41","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.str.2011.08.003","volume":"19","author":"Adrian\u00a0W.R. Serohijos","year":"2011","unstructured":"Serohijos AW, Yin S, Ding F, Gauthier J, Gibson DG, Maixner W et al (2011) Structural basis for \u03bc-opioid receptor binding and activation. Structure 19(11):1683\u20131690","journal-title":"Structure"},{"issue":"3","key":"1443_CR42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/02791072.2017.1290303","volume":"49","author":"Alireza Sharafshah","year":"2017","unstructured":"Sharafshah A, Fazel H, Albonaim A, Omarmeli V, Rezaei S, Mirzajani E et al (2017) Association of OPRD1 gene variants with opioid dependence in addicted male individuals undergoing methadone treatment in the North of Iran. J Psychoactive Drugs 49(3):242\u2013251","journal-title":"Journal of Psychoactive Drugs"},{"issue":"4","key":"1443_CR43","first-page":"459","volume":"19","author":"Jinxiu Shi","year":"2002","unstructured":"Shi J, Hui L, Xu Y, Wang F, Huang W, Hu GJH m (2002) Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Human mutation 19(4):459\u2013460","journal-title":"Human Mutation"},{"issue":"2","key":"1443_CR44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biopsych.2008.09.009","volume":"65","author":"Toni S. Shippenberg","year":"2009","unstructured":"Shippenberg TS, Chefer VI, Thompson ACJB p (2009) Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biological Psychiatry 65(2):169\u2013174","journal-title":"Biological Psychiatry"},{"issue":"4","key":"1443_CR45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/prot.340170404","volume":"17","author":"MJ Sippl","year":"1993","unstructured":"Sippl MJ (1993) Recognition of errors in three-dimensional structures of proteins. Proteins: Structure, Function, and Bioinformatics 17(4):355\u2013362","journal-title":"Proteins: Structure, Function, and Bioinformatics"},{"issue":"10","key":"1443_CR46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.euroneuro.2012.02.002","volume":"22","author":"Sheng-Chang Wang","year":"2012","unstructured":"Wang S-C, Tsou H-H, Chen C-H, Chen Y-T, Ho K, Hsiao C-F et al (2012) Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients. European Neuropsychopharmacology 22(10):695\u2013703","journal-title":"European Neuropsychopharmacology"},{"issue":"suppl_2","key":"1443_CR47","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic acids research 35(suppl_2):W407\u2013W410","journal-title":"Nucleic acids research"},{"issue":"2","key":"1443_CR48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/clinchem\/37.2.205","volume":"37","author":"Kim Wolff","year":"1991","unstructured":"Wolff K, Sanderson M, Hay A, Raistrick DJCC (1991) Methadone concentrations in plasma and their relationship to drug dosage. Clin Chem 37(2):205\u2013209","journal-title":"Clinical Chemistry"},{"issue":"D1","key":"1443_CR49","doi-asserted-by":"crossref","first-page":"D1096","DOI":"10.1093\/nar\/gks966","volume":"41","author":"J Yang","year":"2012","unstructured":"Yang J, Roy A, Zhang Y (2012) BioLiP: a semi-manually curated database for biologically relevant ligand\u2013protein interactions. Nucleic acids research 41(D1):D1096\u2013D1103","journal-title":"Nucleic acids research"},{"issue":"20","key":"1443_CR50","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/bioinformatics\/btt447","volume":"29","author":"J Yang","year":"2013","unstructured":"Yang J, Roy A, Zhang Y (2013) Protein\u2013ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment. Bioinformatics 29(20):2588\u20132595","journal-title":"Bioinformatics"},{"issue":"38","key":"1443_CR51","doi-asserted-by":"crossref","first-page":"32618","DOI":"10.1074\/jbc.M504942200","volume":"280","author":"Ying Zhang","year":"2005","unstructured":"Zhang Y, Wang D, Johnson AD, Papp AC, Sad\u00e9e WJJoBC (2005) Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 280(38):32618\u201332624","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"1443_CR52","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/hmg\/ddl024","volume":"15","author":"Huiping Zhang","year":"2006","unstructured":"Zhang H, Luo X, Kranzler HR, Lappalainen J, Yang B-Z, Krupitsky E et al (2006) Association between two \u03bc-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Human Molecular Genetics 15(6):807\u2013819","journal-title":"Human Molecular Genetics"},{"issue":"11","key":"1443_CR53","first-page":"1244","volume":"61","author":"D Zhang","year":"2007","unstructured":"Zhang D, Shao C, Shao M, Yan P, Wang Y, Liu Y et al (2007) Effect of \u03bc-opioid receptor gene polymorphisms on heroin-induced subjective responses in a. Chinese population. 61(11):1244\u20131251","journal-title":"Chinese population."}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-019-01443-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-019-01443-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-019-01443-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:43:21Z","timestamp":1608165801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-019-01443-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1007\/s12031-019-01443-4","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"type":"print","value":"0895-8696"},{"type":"electronic","value":"1559-1166"}],"subject":[],"published":{"date-parts":[[2019,12,18]]},"assertion":[{"value":"23 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}